Pathological Mechanisms and Diagnostic and Therapeutic Advances of Immune Checkpoint Inhibitor-Related Myocarditis
Abstract：Immune checkpoint inhibitors (ICIs) enhance the immune response by inhibiting the 'brake' effect of immune checkpoints on the surface of lymphocytes, and have become a hotspot in the treatment of patients with advanced solid tumors in recent years.
Machine-generated Keywords：
Publication Date：2025-08-20
Online Publishing Date：2025-10-24(First online date of this platform, not the publication date of the document)
Pages：5( 1017-1021 )